STREPTOKINASE

Course overview

STREPTOKINASE CAN BE USEFUL IN THE MANAGEMENT AND TREATMENT OF ACUTE ST-SEGMENT MYOCARDIAL INFARCTION, DEEP VEIN THROMBOSIS, PULMONARY EMBOLISM, ARTERIAL THROMBOSIS OR EMBOLISM, AND ARTERIOVENOUS CANNULA OCCLUSION. IT IS IN THE THROMBOLYTIC CLASS OF MEDICATIONS. THIS ACTIVITY REVIEWS THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR STREPTOKINASE AS A VALUABLE AGENT IN THE TREATMENT OF THROMBOTIC AND EMBOLIC DISORDERS. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS (E.G., OFF-LABEL USES, DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, MONITORING, RELEVANT INTERACTIONS) PERTINENT FOR MEMBERS OF THE INTERPROFESSIONAL TEAM HEALTHCARE TEAM IN THE TREATMENT OF PATIENTS WITH THROMBOTIC AND EMBOLIC EVENTS AND RELATED CONDITIONS. IT IS NO LONGER COMMERCIALLY AVAILABLE IN THE UNITED STATES.